Wolverine Asset Management LLC Sage Therapeutics, Inc. Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $89,900 - $128,107	-2,233 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $122,547 - $177,054	2,233 New	2,233 $126,000
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $1,130 - $1,548	-16 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $934 - $1,424	16 New	16 $1,000
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $67,083 - $101,855	-1,631 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $42,324 - $70,377	1,631 New	1,631 $67,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $303M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.